Alvotech (ALVOW) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 26Sep 4Sep 16Sep 22Sep 28Oct 2Oct 8Oct 14

Key dataOct 14, 2026

Open$0.26

From 52W high−86.67%

Volume5.00

Market cap$78.06M

P/E (TTM)—

P/S (TTM)0.2x

Div yield—

Key dataOct 14, 2026

Open

$0.26

From 52W high

−86.67%

Volume

5.00

Market cap

$78.06M

ValuationView details →

P/E (Fwd)

1.1x

EV/EBITDA

212.3x

P/E (TTM)

—

RSI (14)

45.5

MomentumView details →

1D Return

−42.17%

YTD Return

−59.99%

ValuationView details →

P/E (Fwd)

1.1x

P/E (TTM)

—

EV/EBITDA

212.3x

EV/Sales

2.8x

P/S (TTM)

0.2x

P/B (TTM)

−0.4x

ProfitabilityView details →

Gross Margin

60.45%

Net Margin

−36.51%

EBITDA Margin

1.33%

ROE (TTM)

93.79%

ROA (TTM)

−11.31%

Asset Turnover

0.33x

GrowthView details →

Revenue YoY

−12.17%

EPS YoY

—

FCF YoY

—

Revenue CAGR 3Y

+91.85%

EPS CAGR 3Y

+111.49%

EBITDA YoY

−96.85%

MomentumView details →

1D Return

−42.17%

YTD Return

−59.99%

1Y Return

−83.01%

RSI (14)

45.5

vs 50D SMA

−5.38%

vs 200D SMA

−37.52%

Capital & dividendView details →

Debt/Equity

−7.58x

Current Ratio

1.65x

Quick Ratio

0.96x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

−$0.09

EPS Surprise

−74.77%

Beats (12Q)

2/12

Next Q EPS Est

$0.17

Avg Surprise (4Q)

−2218.09%

Rev Surprise

2.91%

Financials snapshotView financials →

Revenue (TTM)

491.95M

Net Income (TTM)

−179.59M

Op. CF (TTM)

−198.70M

Next earningsNov 11, 2026 →

Latest newsMore news →

Alvotech and Advanz Pharma Corp. Ltd. announced that AVT29 was submitted to the EUROPEAN MEDICINES AGENCY as a line extension to the existing marketing authorization for Mynzepli (aflibercept 2 mg).6d ago

Alvotech and Lotte Biologics Co., Ltd. announced a long-term manufacturing partnership under which Lotte Biologics Co., Ltd. will produce drug substance for multiple Alvotech antibody biosimilar products at its Syracuse, New York facility for global supply.13d ago

Similar companies

Huakang Biomedical Holdings Company Limited08622.HK InterCure Ltd.INCR Cumberland Pharmaceuticals Inc.CPIX Qianhai Health Holdings Limited00911.HK Procaps Group S.A.PROC Talphera, Inc.TLPH Find similar companies →

Latest newsMore news →

Alvotech and Advanz Pharma Corp. Ltd. announced that AVT29 was submitted to the EUROPEAN MEDICINES AGENCY as a line extension to the existing marketing authorization for Mynzepli (aflibercept 2 mg).6d ago Alvotech and Lotte Biologics Co., Ltd. announced a long-term manufacturing partnership under which Lotte Biologics Co., Ltd. will produce drug substance for multiple Alvotech antibody biosimilar products at its Syracuse, New York facility for global supply.13d ago The FDA approved additional U.S. manufacturing capacity allowing Alvotech's SIMLANDI (AVT02) drug substance to be produced in either of its two Reykjavik drug substance suites.15d ago